furosemide has been researched along with Cancer of Lung in 20 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aerosol furosemide may be an option to treat refractory dyspnea, though doses, methods of delivery, and outcomes have been variable." | 9.34 | Controlled Delivery of 80 mg Aerosol Furosemide Does Not Achieve Consistent Dyspnea Relief in Patients. ( Banzett, RB; Hallowell, RW; O'Donnell, CR; Schwartzstein, R; Sheridan, A, 2020) |
| "Our findings do not support a beneficial effect from nebulised furosemide in patients with cancer related breathlessness." | 9.13 | Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer. ( Bell, S; Chauhan, A; El Khoury, B; Feathers, L; Frisby, J; Howard, P; Lewis, M; Manderson, C; Tattersfield, A; Walton, A; Wilcock, A, 2008) |
| "To report a patient with lung cancer and idiopathic myelofibrosis with myeloid metaplasia who developed purpura and acute renal failure while receiving levofloxacin, and review the existing literature on quinolone nephrotoxicity." | 7.71 | Nephrotoxicity and purpura associated with levofloxacin. ( De Simone, C; Famularo, G, 2002) |
| "Aerosol furosemide may be an option to treat refractory dyspnea, though doses, methods of delivery, and outcomes have been variable." | 5.34 | Controlled Delivery of 80 mg Aerosol Furosemide Does Not Achieve Consistent Dyspnea Relief in Patients. ( Banzett, RB; Hallowell, RW; O'Donnell, CR; Schwartzstein, R; Sheridan, A, 2020) |
| "Our findings do not support a beneficial effect from nebulised furosemide in patients with cancer related breathlessness." | 5.13 | Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer. ( Bell, S; Chauhan, A; El Khoury, B; Feathers, L; Frisby, J; Howard, P; Lewis, M; Manderson, C; Tattersfield, A; Walton, A; Wilcock, A, 2008) |
| " Followed by hydration with saline, pamidronate is effective for the control of symptomatic hypercalcemia." | 4.79 | [Paraneoplastic syndrome]. ( Hara, N; Nakanishi, Y; Takayama, K, 1997) |
| "To report a patient with lung cancer and idiopathic myelofibrosis with myeloid metaplasia who developed purpura and acute renal failure while receiving levofloxacin, and review the existing literature on quinolone nephrotoxicity." | 3.71 | Nephrotoxicity and purpura associated with levofloxacin. ( De Simone, C; Famularo, G, 2002) |
| "The furosemide arm was characterized by relatively high urine output after cisplatin administration (900 vs 550 mL/h), low frequency of unplanned additional hydration (14% vs 32%), and high incidence of hyponatremia (18% and 5%) compared with the mannitol arm." | 3.01 | Randomized study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in non-small cell lung cancer: The OLCSG1406 trial. ( Hara, N; Hata, Y; Hotta, K; Ichihara, E; Itano, J; Kano, H; Kiura, K; Kubo, T; Maeda, Y; Makimoto, G; Minami, D; Nakanishi, M; Nakasuka, T; Ninomiya, K; Ninomiya, T; Nishii, K; Ohashi, K; Oze, I; Sato, A; Tabata, M; Watanabe, H, 2021) |
| "However, she experienced recurrence with positive T790 M, and osimertinib (80 mg/day) was administered as the 2nd line therapy." | 1.56 | Osimertinib induced cardiomyopathy: A case report. ( Ishikawa, K; Kagamu, H; Kaira, K; Shinomiya, S; Yamaguchi, O, 2020) |
| "A radiograph demonstrated pulmonary edema; echocardiography revealed an ostium secundum atrial septal defect with increased flow to the lung and severe pulmonary hypertension." | 1.37 | [Postoperative management of postpneumonectomy pulmonary edema in a patient with ostium secundum atrial septal defect]. ( Barberá, M; Marchante, M; Navarro, JL; Ramos, F; Vicente, R, 2011) |
| "Treatment with sodium thiosulfate (STS) blocked carboplatin cytotoxicity against the LX-1 human small cell lung carcinoma cell line in vitro." | 1.29 | In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity. ( Brummett, RE; Guitjens, S; Kroll, RA; McCormick, CI; Muldoon, LL; Neuwelt, EA; Pagel, MA; Remsen, LG, 1996) |
| "Hypercalcemia is very uncommon in small cell (oat cell) carcinoma of the lung." | 1.25 | Hypercalcemia in small cell (oat cell) carcinoma of the lung. Coincident parathyroid adenoma in one case. ( Bowman, DM; Dubé, WJ; Levitt, M, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hallowell, RW | 1 |
| Schwartzstein, R | 1 |
| O'Donnell, CR | 1 |
| Sheridan, A | 1 |
| Banzett, RB | 1 |
| Makimoto, G | 2 |
| Hotta, K | 2 |
| Oze, I | 2 |
| Ninomiya, K | 2 |
| Nakanishi, M | 1 |
| Hara, N | 2 |
| Kano, H | 1 |
| Watanabe, H | 1 |
| Hata, Y | 1 |
| Nishii, K | 1 |
| Nakasuka, T | 1 |
| Itano, J | 1 |
| Ninomiya, T | 2 |
| Kubo, T | 2 |
| Ohashi, K | 2 |
| Ichihara, E | 2 |
| Minami, D | 2 |
| Sato, A | 1 |
| Tabata, M | 2 |
| Maeda, Y | 2 |
| Kiura, K | 2 |
| Shinomiya, S | 1 |
| Kaira, K | 1 |
| Yamaguchi, O | 1 |
| Ishikawa, K | 1 |
| Kagamu, H | 1 |
| Martins-Filho, PR | 1 |
| Kameo, SY | 1 |
| Mascarenhas-Oliveira, AC | 1 |
| Vieira, NF | 1 |
| Azevedo, E | 1 |
| Rea, G | 1 |
| Valente, T | 1 |
| de Rosa, N | 1 |
| Muto, M | 1 |
| Berritto, D | 1 |
| Bocchino, M | 1 |
| Marchante, M | 1 |
| Ramos, F | 1 |
| Vicente, R | 1 |
| Navarro, JL | 1 |
| Barberá, M | 1 |
| Famularo, G | 1 |
| De Simone, C | 1 |
| Wilcock, A | 1 |
| Walton, A | 1 |
| Manderson, C | 1 |
| Feathers, L | 1 |
| El Khoury, B | 1 |
| Lewis, M | 1 |
| Chauhan, A | 1 |
| Howard, P | 1 |
| Bell, S | 1 |
| Frisby, J | 1 |
| Tattersfield, A | 1 |
| Folco, G | 1 |
| Bolla, M | 1 |
| Santinelli, E | 1 |
| Bianco, S | 1 |
| Sestini, P | 1 |
| Mezzetti, M | 1 |
| Sala, A | 1 |
| Sandström, PE | 1 |
| Jonsson, O | 1 |
| Grankvist, K | 1 |
| Henriksson, R | 1 |
| Stone, P | 1 |
| Kurowska, A | 1 |
| Tookman, A | 1 |
| Yoshimura, A | 1 |
| Yamano, Y | 1 |
| Gemma, A | 1 |
| Yoshimori, K | 1 |
| Hayashihara, K | 1 |
| Taniguchi, Y | 1 |
| Uematsu, K | 1 |
| Shibuya, M | 1 |
| Kudoh, S | 1 |
| Niitani, H | 1 |
| Cullen, MH | 1 |
| Neuwelt, EA | 1 |
| Brummett, RE | 1 |
| Remsen, LG | 1 |
| Kroll, RA | 1 |
| Pagel, MA | 1 |
| McCormick, CI | 1 |
| Guitjens, S | 1 |
| Muldoon, LL | 1 |
| Nakanishi, Y | 1 |
| Takayama, K | 1 |
| Bowman, DM | 1 |
| Dubé, WJ | 1 |
| Levitt, M | 1 |
| Whang, R | 1 |
| Ruffy, R | 1 |
| Banfield, W | 1 |
| Hill, M | 1 |
| Jeon, SH | 1 |
| Chun, W | 1 |
| Choi, YJ | 1 |
| Kwon, YS | 1 |
| Hostanska, K | 1 |
| Jürgenliemk, G | 1 |
| Abel, G | 1 |
| Nahrstedt, A | 1 |
| Saller, R | 1 |
1 review available for furosemide and Cancer of Lung
| Article | Year |
|---|---|
[Paraneoplastic syndrome].
Topics: Alendronate; Anticoagulants; Cushing Syndrome; Diagnosis, Differential; Diphosphonates; Disseminated | 1997 |
6 trials available for furosemide and Cancer of Lung
| Article | Year |
|---|---|
Controlled Delivery of 80 mg Aerosol Furosemide Does Not Achieve Consistent Dyspnea Relief in Patients.
Topics: Administration, Inhalation; Adult; Aerosols; Aged; Aged, 80 and over; Asthma; Chronic Disease; Cross | 2020 |
Randomized study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in non-small cell lung cancer: The OLCSG1406 trial.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Combinations; Female; Furosemide; Human | 2021 |
Randomized Phase II Study Comparing Mannitol with Furosemide for the Prevention of Renal Toxicity Induced by Cisplatin-based Chemotherapy with Short-term Low-volume Hydration in Advanced Non-small Cell Lung Cancer: The OLCSG1406 Study Protocol.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Protocols; Diuretics; Drinking; Fur | 2018 |
Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer.
Topics: Administration, Inhalation; Aged; Cross-Over Studies; Diuretics; Double-Blind Method; Dyspnea; Exerc | 2008 |
[An early phase II trial combining cisplatin and carboplatin in advanced non-small cell lung cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-S | 1993 |
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell | 1993 |
13 other studies available for furosemide and Cancer of Lung
| Article | Year |
|---|---|
Osimertinib induced cardiomyopathy: A case report.
Topics: Acrylamides; Adenocarcinoma of Lung; Adrenergic beta-Antagonists; Afatinib; Aged; Angiotensin-Conver | 2020 |
Pemetrexed-induced eyelid edema in lung cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; Carboplatin; Dexamethasone; Diuretics; Edema | 2013 |
Pulmonary capillary hemangiomatosis: a diagnostic challenge.
Topics: Carbazoles; Carvedilol; Delayed Diagnosis; Disease Progression; Furosemide; Granuloma, Pyogenic; Hum | 2015 |
[Postoperative management of postpneumonectomy pulmonary edema in a patient with ostium secundum atrial septal defect].
Topics: Adenocarcinoma; Amiodarone; Bundle-Branch Block; Combined Modality Therapy; Diuretics; Electric Coun | 2011 |
Nephrotoxicity and purpura associated with levofloxacin.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Diuretics; Drug Eruption | 2002 |
Furosemide attenuates bronchial responsiveness to antigen challenge "in vitro".
Topics: Acetophenones; Acetylcholine; Bronchi; Bronchiectasis; Carcinoma, Bronchogenic; Dicarboxylic Acids; | 1995 |
Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma, prostatic carcinoma and pulmonary carcinoma cell lines.
Topics: Bumetanide; Cell Division; Estramustine; Furosemide; Glioma; Humans; Ion Transport; Lung Neoplasms; | 1994 |
Nebulized frusemide for dyspnoea.
Topics: Administration, Inhalation; Dyspnea; Furosemide; Humans; Lung Neoplasms; Male; Nebulizers and Vapori | 1994 |
In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity.
Topics: Acoustic Stimulation; Animals; Blood-Brain Barrier; Carboplatin; Carcinoma, Small Cell; Cell Line; C | 1996 |
Hypercalcemia in small cell (oat cell) carcinoma of the lung. Coincident parathyroid adenoma in one case.
Topics: Adenoma; Adult; Bone Neoplasms; Calcitonin; Carcinoma, Small Cell; Cyclophosphamide; Furosemide; Hum | 1975 |
Treatment of neoplastic hypercalcemic crisis.
Topics: Bone Neoplasms; Carcinoma, Squamous Cell; Furosemide; Humans; Hydrocortisone; Hypercalcemia; Lung Ne | 1972 |
Cytotoxic constituents from the bark of Salix hulteni.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemia; Cell Line, Tumor; Cell Survival; Chromatography | 2008 |
Willow bark extract (BNO1455) and its fractions suppress growth and induce apoptosis in human colon and lung cancer cells.
Topics: Apoptosis; Carcinoma, Small Cell; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclooxygena | 2007 |